In addition to LRRK2, several other genes, e.g., α-synuclein, PTEN-induced kinase 1 (PINK1), F-box protein 7 (FBXO7), and ubiquitin C-terminal hydrolase L1 (UCHL1) show altered expression in cancer patients [36]. This evidence concerns the gene FBXO7 and cancer.